Paromomycin
- Generic Name
- Paromomycin
- Brand Names
- Humatin
- Drug Type
- Small Molecule
- Chemical Formula
- C23H45N5O14
- CAS Number
- 7542-37-2
- Unique Ingredient Identifier
- 61JJC8N5ZK
Overview
An oligosaccharide antibiotic produced by various streptomyces. [PubChem]
Background
An oligosaccharide antibiotic produced by various streptomyces. [PubChem]
Indication
For the treatment of acute and chronic intestinal amebiasis (it is not effective in extraintestinal amebiasis). Also for the management of hepatic coma as adjunctive therapy.
Associated Conditions
- Dientamoeba fragilis infection
- Hepatic coma
- Acute Intestinal amebiasis
- Chronic Intestinal amebiasis
Clinical Trials
FDA Approved Products
Paromomycin Sulfate
Manufacturer:Department of State Health Services, Pharmacy Branch
Route:ORAL
Strength:250 mg in 1 1
Approved: 2016/02/09
NDC:55695-022
Humatin
Manufacturer:Waylis Therapeutics LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/03/26
NDC:80725-250
Paromomycin Sulfate
Manufacturer:Central Texas Community Health Centers
Route:ORAL
Strength:250 mg in 1 1
Approved: 2017/11/07
NDC:76413-147
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath